Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00020579 · ClinicalTrials.gov registry record · Phase 1

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

A Phase 1 study of Cancer, sponsored by National Institutes of Health Clinical Center (CC).

Completed
Registry status
Phase 1
Development phase
75
Enrollment target
3
Study locations

NCT00020579 is a Phase 1 study of Cancer that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 75 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00020579, a Phase 1 study of Cancer, has completed, sponsored by National Institutes of Health Clinical Center (CC).

COMPLETED
Registry status
Phase 1
Development phase
75 participants
Enrollment target
3
Study locations

Study Summary

RATIONALE: MS-275 may stop the growth of cancer cells by blocking the enzymes necessary for their growth. PURPOSE: This phase I trial is studying the side effects and best dose of MS-275 in treating patients with advanced solid tumors or lymphoma.

Conditions Studied

Cancer

Interventions

  • DRUG entinostat

Study Locations (3)

Maryland

  • National Naval Medical Center - Bethesda
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support - Bethesda
  • NCI - Center for Cancer Research - Bethesda

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2001-03
Est. Completion 2008-10
Phase Phase 1

Sponsor

National Institutes of Health Clinical Center (CC)

338 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00020579

The ClinicalTrials.gov registry entry for NCT00020579 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which entinostat is the first listed.

NCT00020579 reports 3 study locations spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00020579 about?

NCT00020579 is a clinical study titled "MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma". RATIONALE: MS-275 may stop the growth of cancer cells by blocking the enzymes necessary for their growth. PURPOSE: This phase I trial is studying the side effects and best dose of MS-275 in treating patients with advanced solid tumors or lymphoma.

What is the current status of trial NCT00020579?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 75 participants. The study started on 2001-03. Estimated completion is 2008-10.

What conditions does trial NCT00020579 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT00020579?

The interventions under investigation include: entinostat (DRUG).

Who is sponsoring clinical trial NCT00020579?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00020579 being conducted?

This trial has 3 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cancer

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.